[RDHL] YoY Quarter Result on 31-Mar-2019 [#Q1]

Stock
[RDHL] RedHill Biopharma Ltd.
Announcement Date
26-Feb-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -28.45%
YoY- 0.65%
Quarter Report
RDHL's Result
RDHL's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 18,236 20,575 1,056 1,737 2,445 0 0 -
PBT -17,137 -22,863 -17,157 -9,870 -9,935 -8,596 -5,524 20.75%
Tax 10 42 214 374 134 5 380 -45.44%
NP -17,137 -22,863 -17,157 -9,870 -9,935 -8,596 -5,524 20.75%
Tax Rate - - - - - - - -
Total Cost 35,373 43,438 18,213 11,607 12,380 8,596 5,524 36.25%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin -93.97 -111.12 -1,624.72 -568.22 -406.34 0.00 0.00 -
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
EPS -13.36 -21.29 -19.46 -13.92 -18.64 -20.22 -17.38 -4.28%
EPS Diluted -13.36 -21.29 -19.46 -13.92 -18.64 -20.22 -17.38 -4.28%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.